[Solubilization of therapeutically used arylamines by n-propylaminoacetylation. Bioactivation of drugs].
D000814:Aniline Compounds; D000818:Animals; D001669:Biochemical Phenomena; D001671:Biochemistry; D002273:Carcinogens; D002626:Chemistry, Pharmaceutical; D003622:Dapsone; D004950:Esterases / Q000302:isolation & purification / Q000494:pharmacology; D008862:Microsomes, Liver / Q000032:analysis; D011437:Propylamines; D012995:Solubility; D013057:Spectrum Analysis; D013449:Sulfonamides; D013552:Swine
D000814:Aniline Compounds; D002273:Carcinogens; D011437:Propylamines; D013449:Sulfonamides; D003622:Dapsone; D004950:Esterases
Die Solubilisierung therapeutisch verwendeter Arylamine durch n-Propylaminoacetylierung. Ein Beitral zur Bioaktivierung von Arzneistoffen.